Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04).
Arathi MohanKent A GriffithFulei WuchuDavid B ZhenChandan Kumar-SinhaOxana CryslerDavid HsiehchenThomas EnzlerDominique DippmanValerie GunchickAbhinav AchrejaOlamide AnimasahunSrinadh ChopparaMinal NenwaniArul M ChinnaiyanDeepak NagrathMark M ZalupskiVaibhav SahaiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Devimistat in combination with GC is well tolerated and has an acceptable safety profile in patients with untreated advanced BTC.